RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value: $989M (100.0% shares, 0.0% debt)

Holdings (28)

— ACHILLION PHARMACEUTICALS INC 17.2%
Value $170M Shares 22,486,007 Share Price $7.57 Est. Cost/Share $4.78 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 12.0%
Value $119M Shares 5,250,000 Share Price $22.59 * Est. Cost/Share $13.77 Unrealized @ Report Date +51.6%
— DYAX CORP 9.7%
Value $95.83M Shares 9,982,578 Share Price $9.60 Est. Cost/Share $8.24 Unrealized @ Report Date —
SGMO SANGAMO BIOSCIENCES INC 9.3%
Value $91.62M Shares 6,000,000 Share Price $15.27 * Est. Cost/Share $9.24 Unrealized @ Report Date +55.7%
ENTA ENANTA PHARMACEUTICALS INC 6.7%
Value $66.31M Shares 1,539,586 Share Price $43.07 * Est. Cost/Share $36.32 Unrealized @ Report Date +5.0%
— DICERNA PHARMACEUTICALS INC 5.5%
Value $54.81M Shares 2,428,571 Share Price $22.57 Est. Cost/Share $28.25 Unrealized @ Report Date —
— VERSARTIS INC 5.1%
Value $50.11M Shares 1,203,002 Share Price $41.65 Est. Cost/Share $41.65 Unrealized @ Report Date —
SGMO SANGAMO BIOSCIENCES INC 4.3%
Value $42.62M Shares 2,791,305 Share Price $15.27 * Est. Cost/Share $9.24 Unrealized @ Report Date +55.7%
BCRX BIOCRYST PHARMACEUTICALS 4.1%
Value $40.78M Shares 3,198,529 Share Price $12.75 * Est. Cost/Share $5.07 Unrealized @ Report Date +91.8%
— SUNESIS PHARMACEUTICALS INC 3.2%
Value $31.75M Shares 4,869,261 Share Price $6.52 Est. Cost/Share $5.18 Unrealized @ Report Date —
— NOVAVAX INC 3.1%
Value $30.78M Shares 6,661,731 Share Price $4.62 Est. Cost/Share $2.24 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS IN 2.3%
Value $22.71M Shares 3,000,000 Share Price $7.57 Est. Cost/Share $4.78 Unrealized @ Report Date —
— DYNAVAX TECHNOLOGIES CORP 2.3%
Value $22.46M Shares 14,036,590 Share Price $1.60 Est. Cost/Share $1.67 Unrealized @ Report Date —
— OPHTHOTECH CORP 2.3%
Value $22.34M Shares 527,941 Share Price $42.31 Est. Cost/Share $32.61 Unrealized @ Report Date —
— REPROS THERAPEUTICS INC 2.1%
Value $21.09M Shares 1,219,381 Share Price $17.30 Est. Cost/Share $17.74 Unrealized @ Report Date —
— BLUEBIRD BIO INC 2.0%
Value $19.4M Shares 503,062 Share Price $38.57 Est. Cost/Share $27.78 Unrealized @ Report Date —
— THERAPEUTICSMD INC 1.9%
Value $19.02M Shares 4,303,066 Share Price $4.42 Est. Cost/Share $3.00 Unrealized @ Report Date —
AKBA AKEBIA THERAPEUTICS INC 1.7%
Value $16.6M Shares 597,363 Share Price $27.79 * Est. Cost/Share $24.08 Unrealized @ Report Date 0.0%
XNCR XENCOR INC 1.2%
Value $11.81M Shares 1,016,735 Share Price $11.62 * Est. Cost/Share $8.58 Unrealized @ Report Date +14.5%
— PSIVIDA CORP 1.1%
Value $11.09M Shares 2,555,659 Share Price $4.34 Est. Cost/Share $4.04 Unrealized @ Report Date —
— ARROWHEAD RESH CORP 0.9%
Value $8.648M Shares 604,346 Share Price $14.31 Est. Cost/Share $9.89 Unrealized @ Report Date —
— SCYNEXIS INC 0.7%
Value $6.737M Shares 840,000 Share Price $8.02 Est. Cost/Share $8.02 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.4%
Value $3.987M Shares 666,667 Share Price $5.98 Est. Cost/Share $7.89 Unrealized @ Report Date —
— OCERA THERAPEUTICS INC 0.4%
Value $3.749M Shares 490,697 Share Price $7.64 Est. Cost/Share $11.51 Unrealized @ Report Date —
— IMMUNOMEDICS INC 0.4%
Value $3.65M Shares 1,000,000 Share Price $3.65 Est. Cost/Share $3.65 Unrealized @ Report Date —
— OXYGEN BIOTHERAPEUTICS INC 0.1%
Value $1.286M Shares 315,298 Share Price $4.08 Est. Cost/Share $4.08 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 0.1%
Value $1.023M Shares 68,968 Share Price $14.83 * Est. Cost/Share $17.10 Unrealized @ Report Date -17.5%
— PRANA BIOTECHNOLOGY LTD 0.0%
Value $227K Shares 100,000 Share Price $2.27 Est. Cost/Share — Unrealized @ Report Date —